U.S. News & World Report released its debut ratings of 20 direct-to-consumer GLP-1 telehealth platforms on Aug. 12, weighting clinical support and screening rigor most heavily and leaving out every company that sells only compounded versions of the drugs. U.S. News & World Report published its first ratings of GLP-1 telehealth platforms on Aug. 12, […]
